Containing 2019-nCoV (Wuhan) coronavirus

被引:0
作者
Edward H. Kaplan
机构
[1] Yale School of Management,William N. and Marie A. Beach Professor of Operations Research, Professor of Public Health, Professor of Engineering
来源
Health Care Management Science | 2020年 / 23卷
关键词
Coronavirus; Containment; Isolation; Quarantine; Probability modeling;
D O I
暂无
中图分类号
学科分类号
摘要
The novel coronavirus 2019-nCoV first appeared in December 2019 in Wuhan, China. While most of the initial cases were linked to the Huanan Seafood Wholesale Market, person-to-person transmission has been verified. Given that a vaccine cannot be developed and deployed for at least a year, preventing further transmission relies upon standard principles of containment, two of which are the isolation of known cases and the quarantine of persons believed at high risk of exposure. This note presents probability models for assessing the effectiveness of case isolation and quarantine within a community during the initial phase of an outbreak with illustrations based on early observations from Wuhan.
引用
收藏
页码:311 / 314
页数:3
相关论文
共 50 条
  • [21] DFT investigation of atazanavir as potential inhibitor for 2019-nCoV coronavirus M protease
    Shahab, Siyamak
    Sheikhi, Masoome
    Alnajjar, Radwan
    Al Saud, Sultan
    Khancheuski, Maksim
    Strogova, Aleksandra
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1228
  • [22] Recent Advances Towards Drug Design Targeting the Protease of 2019 Novel Coronavirus (2019-nCoV)
    Bano, Sehrish
    Hameed, Abdul
    Al-Rashida, Mariya
    Iflikhar, Shafia
    Iqbal, Jamshed
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (22) : 4484 - 4498
  • [23] Comments on "Cross-species transmission of the newly identified coronavirus 2019-nCoV"
    Qian, Jiating
    Feng, Yifan
    Li, Jie
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) : 1437 - 1439
  • [24] An Approach of Risk Analysis and The Potential Effects of The Occurrence of 2019-Ncov Coronavirus in Romania
    Nica, Ionut
    Chirita, Nora
    EDUCATION EXCELLENCE AND INNOVATION MANAGEMENT: A 2025 VISION TO SUSTAIN ECONOMIC DEVELOPMENT DURING GLOBAL CHALLENGES, 2020, : 8761 - 8770
  • [25] Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
    Shanmugaraj, Balamurugan
    Malla, Ashwini
    Phoolcharoen, Waranyoo
    PATHOGENS, 2020, 9 (02):
  • [26] Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
    Kumar S.
    Maurya V.K.
    Prasad A.K.
    Bhatt M.L.B.
    Saxena S.K.
    VirusDisease, 2020, 31 (1) : 13 - 21
  • [27] The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future
    Li, Jin-Yan
    You, Zhi
    Wang, Qiong
    Zhou, Zhi-Jian
    Qiu, Ye
    Luo, Rui
    Ge, Xing-Yi
    MICROBES AND INFECTION, 2020, 22 (02) : 80 - 85
  • [28] A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV)
    Dong, Shengjie
    Sun, Jiachen
    Mao, Zhuo
    Wang, Lu
    Lu, Yi-Lin
    Li, Jiesen
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (09) : 1542 - 1548
  • [29] Triazavirin- Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study
    Shahab, Siyamak
    Sheikhi, Masoome
    CURRENT MOLECULAR MEDICINE, 2021, 21 (08) : 645 - 654
  • [30] A FUZZY-BASED STRATEGY TO SUPPRESS THE NOVEL CORONAVIRUS (2019-NCOV) MASSIVE OUTBREAK
    Zhao, Tie-Hong
    Castillo, Oscar
    Jahanshahi, Hadi
    Yusuf, Abdullahi
    Alassafi, Madini O.
    Alsaadi, Fawaz E.
    Chu, Yu-Ming
    APPLIED AND COMPUTATIONAL MATHEMATICS, 2021, 20 (01) : 160 - 176